ILLUMINA, INC. ILMN

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $190.81
Market Cap $29.14B
P/E Ratio 35.01
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-0.7% YoY
$4.34B
3-Yr CAGR: -1.4%
Net Income ↑169.5% YoY
$850.00M
Net Margin: 19.6%
Free Cash Flow ↑31.3% YoY
$931.00M
FCF Yield: 3.19%
EPS (Diluted) ↑170.9% YoY
$5.45
Basic: $5.47
Return on Equity Efficiency
31.2%
ROA: 12.8%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ILMN)

All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
  • FY 2022: Revenue YoY (+0.0%) is identical to Gross Profit YoY (+0.0%). Verify the underlying Revenue and Gross Profit values for FY 2022 and FY 2021.
  • FY 2022: Revenue YoY (+0.0%) is identical to Net Income YoY (+0.0%). Verify the underlying Revenue and Net Income values for FY 2022 and FY 2021.
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $2,219.8M $1,549.3M $461.6M $2.93 $659.6M $516.7M
FY 2017 $2,752.0M +24.0% $1,826.0M $726.0M +57.3% $4.66 +58.7% $875.0M $565.0M +9.3%
FY 2018 $3,333.0M +21.1% $2,300.0M $826.0M +13.8% $5.26 +13.0% $1,142.0M $846.0M +49.7%
FY 2019 $3,543.0M +6.3% $2,467.0M $1,002.0M +21.3% $6.38 +21.2% $1,051.0M $842.0M -0.5%
FY 2020 $3,239.0M -8.6% $2,203.0M $656.0M -34.5% $4.21 -34.0% $1,080.0M $891.0M +5.8%
FY 2021 $4,526.0M +39.7% $3,154.0M $762.0M +16.2% $4.77 +13.3% $545.0M $337.0M -62.2%
FY 2022 $4,526.0M 0.0% $3,154.0M $762.0M 0.0% $4.77 0.0% $96.0M $-112.0M -133.2%
FY 2023 $4,504.0M -0.5% $2,744.0M $-1,161.0M -252.4% $-6.95 -245.6% $478.0M $283.0M +352.7%
FY 2024 $4,372.0M -2.9% $2,861.0M $-1,223.0M -5.3% $-7.69 -10.7% $837.0M $709.0M +150.5%
FY 2025 $4,343.0M -0.7% $2,870.0M $850.0M +169.5% $5.45 +170.9% $1,079.0M $931.0M +31.3%
$

Valuation

Market Price $190.81
Market Cap $29.14B
Enterprise Value N/A
P/E Ratio 35.01
P/B Ratio 10.60
FCF Yield 3.19%
Dividend Yield N/A
Shares Outstanding 151,300,000
%

Profitability & Margins

Gross Margin 66.08%
Operating Margin 18.58%
Net Margin 19.57%
Return on Equity (ROE) 31.22%
Return on Assets (ROA) 12.79%
Asset Turnover 0.65x
Revenue 3-Yr CAGR -1.37%
🛡️

Financial Health & Liquidity

Current Ratio 0.28
Cash Ratio 1.68
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $1.42B
Total Debt N/A
Book Value / Share $18.00
💧

Cash Flow Efficiency

Operating Cash Flow $1.08B
Capital Expenditures (CapEx) $148.00M
Free Cash Flow $931.00M
OCF / Revenue 24.84%
FCF / Revenue 21.44%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $5.45
EPS (Basic) $5.47
Dividends / Share N/A
Book Value / Share $18.00
EPS YoY Growth 170.87%
🏛️

Balance Sheet (FY 2025)

Total Assets $6.64B
Total Liabilities $6.64B
Stockholders' Equity $2.72B
Current Assets $238.00M
Current Liabilities $846.00M